Global Markets and Technologies for Cell and Tissue Analysis

Report Code: BIO068D

Publish Date: Apr 2023

Publisher: BCC Publishing

Category: Cell Biology

Download Report Overview

Single User License: $5500

Member Price: FREE

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global cell and tissue analysis market should reach $28.9 billion by 2027 from $18.2 billion in 2022 at a compound annual growth rate (CAGR) of 9.6% for the forecast period of 2022 to 2027.

Report Includes

  • 30 data tables and 20 additional tables
  • A detailed overview and an up-to-date analysis of the global market for cell and tissue analysis (CTA) products and technologies
  • Analyses of the global market trends, with market revenue data from 2019 to 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
  • Discussion of the industry growth driving factors and restraints that will shape the market for CTA products as the basis for projecting demand over the next few years (2022-2027)
  • Estimation of the actual market size and revenue forecast for global cell and tissue analysis products market in USD millions, and corresponding market share analysis by type, application, end-user, and region
  • Review of the commercialized products used in the isolation, purification, and analysis of cells, as well as novel products and technologies that may be commercially viable in the next few years
  • Identification of large and established producers in cell and tissue analysis product market segments, as well as numerous smaller specialized market players
  • Insight into the recent industry structure, government regulations and policies, development issues, and the vendor landscape
  • Information about patents and patent applications for cell and tissue analysis products and technologies by each major category
  • Market share analysis of the key market participants, along with their research priorities, product portfolios, and competitive landscape
  • Detailed company profiles of the leading industry players, including Agilent Technologies Inc., Bio-Rad Laboratories Inc., General Electric Healthcare, Merck KGaA, PerkinElmer and Thermo Fisher Scientific Inc.

Report Scope

This report focuses on the global market of cell and tissue analysis (CTA) products and provides an updated review, including basic design and applications in various arenas of biomedical and life science research. The report deals with CTA products covering the total market, which includes three main areas of applications. These are biospecimen preparation techniques, cell separation products, and cell and tissue characterization products. These categories are further subdivided into various types. The report also covers the market for cell and tissue analysis products by end user. The end users of cell and tissue analysis products are categorized as research and academics, biopharmaceuticals, and healthcare and clinical. Excluded from this report are immunoassays.

BCC Research analyzed each market and its application, regulatory environment, new products and advancements, patent analysis, market projections, and market shares. The current report provides a detailed analysis of the market’s drivers, challenges, opportunities, and impact of COVID-19. The report also covers market projections to 2027 and market share for key market players. The report includes the company profiles of the key players with detailed information about their business segments, financials, product portfolios, and recent developments.

Report Synopsis

Report Metrics Details
Base year considered 2021
Forecast period considered 2022 to 2027
Base year market size $16.7 billion
Market size forecast $28.9 billion
Growth rate CAGR of 9.6% for the forecast period of 2022-2027
Units considered $ Millions
Segments covered technology type, end-user, and region
Regions covered North America, Europe, Emerging markets
Key Market Drivers
  • Development of High-End Technology
  • Increasing Demand for Single-Cell Analysis
  • Increasing Prevalence of Diseases
  • Increasing Demand for Personalized Medicine
  • Increasing Investments and Spending for Research and Development
  • Difficulty Obtaining Regulatory Approval
  • High Cost of Instruments
  • Lack of Awareness of the Science
  • Lack of Skilled Professionals
Companies studied
ABCAM PLCABNOVA CORP.
AGILENT TECHNOLOGIES INC.ARRAYIT CORP. (ARYC)
BDBIO-RAD LABORATORIES INC.
BIO-TECHNECARL ZEISS AG
CELL SIGNALING TECHNOLOGY INC.DANAHER CORP.
FUJIFILM CELLULAR DYNAMICS INC. (FCDI)GE HEALTHCARE
F. HOFFMANN-LA ROCHE LTD.ILLUMINA INC.
LUMINEX CORP.MERCK KGAA
MILTENYI BIOTECPERKINELMER INC.
SARTORIUS AGSTEMCELL TECHNOLOGIES
SYSMEX CORP.THERMO FISHER SCIENTIFIC INC.
WORTHINGTON BIOCHEMICAL CORP.
Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW

Frequently Asked Questions (FAQs)

• The global cell and tissue analysis market is estimated to be $16.7 billion in 2021 and is expected to increase to nearly $28.9 billion by 2027, growing at a CAGR of 9.6% during the forecast period.
• The key factors contributing to the growth of the market include increasing investments and funding for research and development, increasing prevalence of chronic diseases, and rising demand for personalised medicines, increasing demand for single-cell analysis and technological advancements are driving the cell and tissue analysis market.
• In this report, the market is segmented based on technology type, end-user, and region.
• Cell and Tissue Characterization segment will dominate the market by the end of 2027.
• North America holds the highest share in the market.
Major players in the market are Thermo Fisher, Danaher, Becton & Dickinson, Agilent Technologies and Illumina.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Let us assist you! Our analysts are ready to tailor this report to your specific need. REACH OUT TO US TODAY

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Global Markets and Technologies for Cell and Tissue Analysis151Free
Chapter- 1: Introduction6Free
Chapter- 2: Summary and Highlights3Free
Chapter- 3: Market and Technology Background12Free
Chapter- 4: Market Dynamics9Free
Chapter- 5: Emerging Technologies2Free
Chapter- 6: Market Breakdown by Technology22Free
Chapter- 7: Market Breakdown by End User17Free
Chapter- 8: Market Breakdown by Region4Free
Chapter- 9: Regulatory Aspects6Free
Chapter- 10: Patent Analysis4Free
Chapter- 11: Competitive Landscape17Free
Chapter- 12: Company Profiles49Free
Published - Mar-2016| Analyst - Shalini Shahani Dewan| Code - BIO068C

Report Highlights

The global cell and tissue analysis products market reached $10.8 billion in 2015 and should reach nearly $12.5 billion by 2020, with a compound annual growth rate (CAGR) of 2.8% through 2020.

Report Includes

  • An overview of the global market for cell and tissue analysis products, including commercialized products used in the isolation, purification, and analysis of cells, as well as novel products and technologies that may be commercially viable in the next few years.
  • Analyses of global market trends, with data from 2014, estimates for 2015, and projections of compound annual growth rates (CAGRs) through 2020.
  • Detailed discussion of biospecimens, enzymatic and mechanical tissue dissociation products, flow cytometry hardware and software, magnetic cell separation products, laser microdissection (LMD) systems, research antibodies, cell-based assays, and products used in high-content screening (HCS) platforms.
  • Profiles of large and established producers in cell and tissue analysis product market segments, as well as numerous smaller specialized market players.
  • Market segmentation within the areas of biospecimen vendors, cell separation products, and cell and tissue analysis products.
  • Examination of each technology by application type and in the context of relevant technological and regulatory forces to determine its current market status and projected growth.
Published - Jan-2013| Analyst - Shalini Shahani Dewan| Code - BIO068B

Report Highlights

The global cell and tissue analysis market was valued at $6.9 billion in 2011 and should reach $7.1 billion in 2012. Total market value is expected to reach $9.6 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 6.2%. 

Report Includes

  • An overview of the global market for cell and tissue analysis products, including commercialized products used in the isolation, purification, and analysis of cells, as well as novel products and technologies that may be commercially viable in the next few years.
  • Analyses of global market trends, with data from 2011, estimates for 2012, and projections of compound annual growth rates (CAGRs) through 2017.
  • Detailed discussion of biospecimens, enzymatic and mechanical tissue dissociation products, flow cytometry hardware and software, magnetic cell separation products, laser microdissection (LMD) systems, research antibodies, cell-based assays, and products used in high-content screening (HCS) platforms.
  • Profiles of large and established producers in cell and tissue analysis product market segments, as well as numerous smaller specialized market players.
  • Market segmentation within the areas of biospecimen vendors, cell separation products, and cell and tissue analysis products.
  • Examination of each technology by application type and in the context of relevant technological and regulatory forces to determine its current market status and projected growth.
Published - Sep-2009| Analyst - Willem Westra| Code - BIO068A

Report Highlights

  • Overall sales in the global market of cell and tissue analysis products were worth $2.6 billion in 2008, which increased to an estimated $2.8 billion in 2009. By 2014, it is projected to increase to $4.5 billion, for a 5-year CAGR of 10.1%.
  • The largest segment of the market, cell and tissue characterization products was valued at $1.2 billion in 2008; this is expected to increase to $1.3 billion in 2009, and is projected to reach $2.2 billion in 2014, for a 5-year CAGR of 10.8%.
  • Sales in the cell separation products segment amounted to $1.2 billion in 2008, increased to an estimated $1.3 billion in 2009, and is projected to increase to $2.1 billion in 2014, for a 5-year CAGR of 9.8%.

Related Reports

Flow Cytometry: Products, Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - BIO085F

The global market for flow cytometry products is expected to grow from $5.2 billion in 2023 to $8.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2029.

Global Markets for Orphan Drugs

Published - Feb 2024 | Publisher - BCC Publishing | Code - PHM038G

The global market for orphan drugs is expected to increase from $233.9 billion in 2023 to $415.2 billion by the end of 2028, with a compound annual growth rate (CAGR) of 12.2% during the forecast period of 2023-2028.

Microbial Products: Technologies, Applications and Global Markets

Published - Jun 2023 | Publisher - BCC Publishing | Code - BIO086E

The global market for microbes and microbial products is estimated to increase from $242.0 billion in 2022 to reach $346.3 billion by 2027, at a compound annual growth rate (CAGR) of 7.4% from 2022 through 2027.

Forensic Technologies: New and Growing Markets

Published - May 2023 | Publisher - BCC Publishing | Code - SAS003G

The global market for forensics technology is estimated to increase from $20.9 billion in 2022 to reach $42.1 billion by 2027, at a compound annual growth rate (CAGR) of 15.0% from 2022 through 2027.

Recent Reports

Gene Synthesis: Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - BIO251A

The global market for Gene Synthesis is estimated to increase from $2.0 billion in 2023 to reach $4.1 billion by 2028, at a compound annual growth rate (CAGR) of 15.8% from 2023 through 2028.

Flow Cytometry: Products, Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - BIO085F

The global market for flow cytometry products is expected to grow from $5.2 billion in 2023 to $8.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2029.

PEGylated Proteins Market

Published - May 2024 | Publisher - BCC Publishing | Code - BIO253A

The global market for PEGylated proteins is expected to grow from $10.2 billion in 2023 and projected to reach $15.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.4% during the forecast period of 2023 to 2028.

Companion Diagnostics: Technologies and Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO077F

The global market for companion diagnostics is estimated to increase from $7.6 billion in 2023 to reach $15.4 billion by 2028, at a compound annual growth rate (CAGR) of 15.2% from 2023 through 2028.

Exosome Diagnostics, Therapeutics and Research Tools: Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO149E

The global market for exosome diagnostics, therapeutics and research tools is estimated to increase from $227.5 million in 2023 to reach $1.3 billion by 2028, at a compound annual growth rate (CAGR) of 42.2% from 2023 through 2028.

Top Trending Reports

Global Market for Cell and Gene Therapy

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO225B

The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028. 

Peptide Synthesis: Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO252A

The global market for peptide synthesis is expected to grow from $90.1 billion in 2023 and projected to reach $157.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.8% during the forecast period of 2023 to 2028.

3D Cell Cultures: Technologies and Global Markets

Published - Mar 2024 | Publisher - BCC Publishing | Code - BIO140D

The global market for 3D cell culture is estimated to increase from $4.6 billion in 2023 to reach $14.8 billion by 2028, at a compound annual growth rate (CAGR) of 26.5% from 2023 through 2028.

Oligonucleotides: Global Markets

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO220B

The global market for oligonucleotides is expected to grow from $7.0 billion in 2023 and projected to reach $11.7 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.

Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - HLC078F

The global market for medical magnetic resonance imaging (MRI) is expected to grow from $7.2 billion in 2023 and projected to reach $9.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2023 to 2028.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Global Markets and Technologies for Cell and Tissue Analysis
Sample Report